Proto Labs (PRLB) Tops Q3 EPS by 15c, provides guidance

Proto Labs (NYSE: PRLB) reported Q3 EPS of $0.47, $0.15 better than the analyst estimate of $0.32. Revenue for the quarter came in at $125.6 million versus the consensus estimate of $121.38 million.

GUIDANCE:

Proto Labs sees Q4 2024 EPS of $0.28-$0.36, versus the consensus of $0.29. Proto Labs sees Q4 2024 revenue of $115-123 million, versus the consensus of $120 million.

For earnings history and earnings-related data on Proto Labs (PRLB) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Nakamoto closes healthcare clinics, completes shift to Bitcoin
• Avis Budget Group reaches $650M settlement with Pentwater Capital